Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
The Annals of Pharmacotherapy|May 24, 2012
Eribulin: a novel cytotoxic chemotherapy agentJessica N Preston, Meghana V Trivedi
Breast Cancer Research : BCR|May 25, 2012
Die and let live: harnessing BikDD to combat breast cancer stem cellsMario Giuliano, Meghana V Trivedi, Rachel Schiff
Breast (Edinburgh, Scotland)|October 22, 2011
Biological mechanisms and clinical implications of endocrine resistance in breast cancerMario Giuliano, Rachel Schifp, C Kent Osborne, et al.
Pharmacoeconomics|March 15, 2023
Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2- Metastatic Breast Cancer in Postmenopausal Women in the USAPrajakta P Masurkar, Haluk Damgacioglu, Ashish A Deshmukh, et al.
Breast (Edinburgh, Scotland)|August 15, 2015
The changing role of ER in endocrine resistanceAgostina Nardone, Carmine De Angelis, Meghana V Trivedi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 4, 2024
Immunomodulator adherence in multiple myeloma patients with lower socioeconomic status: a retrospective studyOnyebuchi Ononogbu, Oyinkansola Akindele, Sahar Yazdanfard, et al.
International Journal of Clinical Pharmacy|June 28, 2023
Adherence to oral endocrine therapy in racial/ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemicSama Rahimi, Onyebuchi Ononogbu, Anjana Mohan, et al.
Pageof 6